ZOLL Medical Corporation to Speak at the 2009 UBS Global Life Sciences Conference

Zoll Medical Corporation (NasdaqGS: ZOLL), a manufacturer of resuscitation devices and related software solutions, today announced that A. Ernest Whiton, its Chief Financial Officer, will speak at 10:00 a.m. on Monday, September 21, 2009 in New York City, at the 2009 UBS Global Life Sciences Conference being held at the Grand Hyatt New York Hotel, 109 East 42^nd Street, New York, NY 10017. He will discuss ZOLL’s business highlights as well as previously disclosed public information.

The audio presentation will be webcast live over the Internet at http://cc.talkpoint.com/ubsx001/092109a_ke/?entity=51_L6P7F0I

About ZOLL Medical Corporation

ZOLL Medical Corporation is committed to developing technologies that help advance the practice of resuscitation and temperature control therapies for the treatment of critical care patients. With products for pacing, defibrillation, circulation, temperature management, and fluid resuscitation, ZOLL provides a comprehensive set of technologies, including Real CPR Help^® and See-Thru CPR^®, which help clinicians, EMS professionals, and lay rescuers resuscitate sudden cardiac arrest or trauma victims. ZOLL also designs and markets software that automates the documentation and management of both clinical and non-clinical information.

ZOLL markets and sells its products in more than 140 countries. The Company has direct operations, distributor networks, and business partners throughout the U.S., Canada, Latin America, Europe, the Middle East and Africa, Asia, and Australia. During 2008 ZOLL marked the 25th anniversary of the Company’s resuscitation product development. For more information, visit www.zoll.com.

©2009 ZOLL Medical Corporation. All rights reserved. 269 Mill Road, Chelmsford, MA 01824-4105.